6505--Fluorouracil RFP

The Department of Veterans Affairs National Acquisition Center seeks supply of Fluorouracil 5% Cream, Topical in 40-gram tubes to support the VA Pharmaceutical Prime Vendor Program and other federal agencies, with proposals due July 8, 2026 at 2:30 PM Central Daylight Time. An amendment issued June 26, 2026 extended the deadline from the original July 1 date; offerors must acknowledge receipt of the amendment prior to proposal submission or face offer rejection.

This is an unrestricted acquisition with no small business set-aside. The estimated annual requirement across all participating agencies (VA, Department of Defense, Indian Health Service, Bureau of Prisons, Federal Health Care Center, and Option 2 State Veteran Homes) is 126,107 tubes. The contract structure consists of a base year plus four one-year option periods, with implementation within up to 60 calendar days following award.

Offerors must submit pricing for the base year and all four option years, including a mandatory 0.5% Cost Recovery Fee. Each offeror must provide a unique 11-digit National Drug Code number specific to their company and product, along with FDA approval documentation (NDA, ANDA, or BLA as applicable). Manufacturing facilities must maintain current acceptable cGMP status with the FDA. Distributor offerors must submit a Letter of Commitment from their manufacturer and obtain their own FDA labeler code.

Contractors must establish business-to-business agreements with PPV contractors, register products with FDA and drug databases within five calendar days of award, comply with Drug Supply Chain Security Act requirements including serialized tracking, implement GS1-128 or HIBCC barcode labeling standards, and submit quarterly sales reports with Cost Recovery Fees within 30 days of each quarter-end. Proposals should be submitted to Amber.Zavala@va.gov and Diana.Martinez1@va.gov. NAICS code is 325412, Pharmaceutical Preparation Manufacturing; PSC is 6505, Drugs and Biologicals.